Pulmonary artery aneurysms in Behcet's syndrome: a review of the literature with emphasis on geographical differences
dc.authorwosid | Çelik, Selda/HLX-7088-2023 | |
dc.contributor.author | Celik, S. | |
dc.contributor.author | Yazici, Y. | |
dc.contributor.author | Sut, N. | |
dc.contributor.author | Yazici, H. | |
dc.date.accessioned | 2024-06-12T10:54:21Z | |
dc.date.available | 2024-06-12T10:54:21Z | |
dc.date.issued | 2015 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Objective. To investigate the frequency of Behcet's syndrome (BS) with pulmonary artery aneurysms (FAA) publications, the most lethal complication of BS, as reported from different countries and to provide a review of diagnostic techniques, treatment approaches and prognosis. Methods. Countries from each continent with a population of 4 million and over were chosen (n=128). A PubMed search for BS, FAA and the country name was conducted and 23 countries with BS and FAA were identified. The, full, texts of articles (n=91) were analysed for data including gender, age, accompanying Vascular findings, diagnostic techniques, treatment modalities and mortality rates. Results. A total of 207 (183 males, 24 females) patients with BS and FAA were reported in 91 articles originating from 23 countries. As expected there was a significant correlation (r=0.88, p<0.001) between the total number of articles about BS (n=4431) and those related to FAA and BS. In a simple linear regression analysis the number of BS and FAA articles from Japan was significantly below the identity line while in Turkey there was a propensity to publish more articles related to FAA than expected. One hundred and sixteen patients (56%) were treated with immunosuppressive therapy. Biologics were used only in 5 patients (2%). Of the 207 patients, 62 (30%) died. Conclusion. FAA is mostly reported as case reports from countries where BS is common. FAA might be uncommon in Japan. The prognosis of FAA could be getting better. | en_US |
dc.identifier.endpage | S59 | en_US |
dc.identifier.issn | 0392-856X | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 26211653 | en_US |
dc.identifier.startpage | S54 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/19018 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000365834600009 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Clinical & Exper Rheumatology | en_US |
dc.relation.ispartof | Clinical And Experimental Rheumatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Behcet's Syndrome | en_US |
dc.subject | Pulmonary Artery Aneurysms | en_US |
dc.subject | Vascular Involvement | en_US |
dc.subject | Disease | en_US |
dc.subject | Manifestations | en_US |
dc.subject | Severity | en_US |
dc.title | Pulmonary artery aneurysms in Behcet's syndrome: a review of the literature with emphasis on geographical differences | en_US |
dc.type | Review Article | en_US |